跳至主要内容
临床试验/EUCTR2006-002351-33-IT
EUCTR2006-002351-33-IT进行中(未招募)不适用

Evaluation of safety and efficacy of intravitreal bevacizumab for macular edema, retinal or choroidal neovascularization or neovascular glaucoma - ND

AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA0 个研究点开始时间: 2006年12月4日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with vascular diseases of the eye, complicated by essudative maculopathy refractory to previous treatment or in which standard therapy is contraindicated or so severe that a favorable response is unpredictable.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Uncontrolled hypertension, coagulation abnormalities, renal or hepatic impairment, myocardial infarction, neoplasms, pregnant or breast-feading women

研究者

发起方
AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA

相似试验

Evaluation of safety and efficacy of intravitreal... | 临床试验